Articles dans des revues avec comité de lecture (60)

  1. 57. Luo, D., Vermijlen, D., Vanderkerken, K., Kuppen, P. J., Seynaeve, C., Eddouks, M., Baekeland, M., & Wisse, E. (1999). Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells. Journal of hepatology, 31(1), 110-116. doi:10.1016/S0168-8278(99)80170-6
  2. 58. Vermijlen, D., Luo, D., Robaye, B., Seynaeve, C., Baekeland, M., & Wisse, E. (1999). Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology, 29(1), 51-56. doi:10.1002/hep.510290143
  3. 59. Wisse, E., Vermijlen, D., Luo, D., Eddouks, M., De Zanger, R., & Braet, F. (1998). The interaction of colon carcinoma cells with rat hepatic sinusoidal cells during early stages of metastasis. World Journal of Gastroenterology, 4, 27.
  4. 60. Wisse, E., Luo, D., Vermijlen, D., Kanellopoulou, C., De Zanger, R., & Braet, F. (1997). On the function of pit cells, the liver-specific natural killer cells. Seminars in liver disease, 17(4), 265-286. doi:10.1055/s-2007-1007204
  5.   Participations à des congrès et colloques internationaux (29)

  6. 1. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence Joint Belgian-Dutch Immunology Meeting 2023 (20-21/11/2023: Flanders Meeting & Convention Center Antwerp, Antwerp, Belgium).
  7. 2. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence 10th Internationnal gd T cell Conference (20-23/06/2023: Chapalimaud Foundation, Lisbon, Portugal).
  8. 3. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence ATCR2023 meeting (03 and 04.05.2023: University of Antwerp).
  9. 4. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence ATCR2023 meeting (3-4 May 2023: University of Antwerp).
  10. 5. Vermijlen, D. (2012). Anti-cancer and anti-viral function of human γδ T cells. Paper session presented at Fourth International Life Sciences Master Research Conference (June 28, 2012: University Hasselt, Belgium.).
  11. 6. Vermijlen, D. (2012). Human fetal blood contains high levels of phosphoantigen-reactive effector-like Vγ9Vδ2 T cells. Paper session presented at Fifth International γδ T cell conference. (May 31-June 2, 2012: Freiburg (Germany)).
  12. 7. Vermijlen, D. (2011). Anti-cancer and anti-viral function of human γδ T cells. Paper session presented at GIGA institute (February 1, 2011: University of Liège, Belgium.).
  13. 8. Vermijlen, D. (2011). Human γδ T cells. Paper session presented at GlaxoSmithKline Biologicals (March 17, 2011: Rixensert, Belgium.).

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>